Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System ; volume:88 ; number:4 ; day:14 ; month:4 ; year:2023 ; pages:551-563 ; date:4.2023
Biochemistry (Moscow) ; 88, Heft 4 (14.4.2023), 551-563, 4.2023
- Creator
-
Eliseeva, Daria D.
Zakharova, Maria N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1134/S0006297923040107
- URN
-
urn:nbn:de:101:1-2023082809371972993145
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eliseeva, Daria D.
- Zakharova, Maria N.
- SpringerLink (Online service)
Other Objects (12)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
An atypical phenotype of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD)
Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
An atypical phenotype of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD)
Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
An atypical phenotype of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD)